![Albert Ferrer Olivera](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Albert Ferrer Olivera
Fondatore presso Invivo Capital Partners SGEIC SA
Posizioni attive di Albert Ferrer Olivera
Società | Posizione | Inizio | Fine |
---|---|---|---|
Invivo Capital Partners SGEIC SA
![]() Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Fondatore | 01/03/2019 | - |
Investitore di Private Equity | 01/03/2019 | - | |
Pulmobiotics SL
![]() Pulmobiotics SL BiotechnologyHealth Technology Pulmobiotics SL operates as a spin off company. The firm uses its technology to discover and develop novel treatments and vaccines for respiratory diseases. The company was founded by Maria Lluch and Lluis Serrano and is headquartered in Barcelona, Spain. | Direttore/Membro del Consiglio | - | - |
GlyCardial Diagnostics SL
![]() GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Direttore/Membro del Consiglio | - | - |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Direttore/Membro del Consiglio | - | - |
Gyala Therapeutics SL
![]() Gyala Therapeutics SL BiotechnologyHealth Technology Gyala Therapeutics SL develops CAR-T therapies for treating hematological malignancies. The company is based in Barcelona, Spain. Claudio Santos has been the CEO of the Spanish company since 2020. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Albert Ferrer Olivera
Precedenti posizioni note di Albert Ferrer Olivera
Società | Posizione | Inizio | Fine |
---|---|---|---|
Riva y García Gestión SGIIC SA /New/
![]() Riva y García Gestión SGIIC SA /New/ Investment ManagersFinance Riva y García Gestión SGIIC SA (Riva y Garcia Private Equity) is a private equity and venture capital subsidiary of Grupo Financiero Riva y García SL /New/ founded in 2000 by Borja García-Nieto Portabella. It is headquartered in Barcelona, Spain. | Analista di Private Equity | 01/08/2004 | 01/01/2007 |
Investitore di Private Equity | 01/01/2007 | 01/03/2017 | |
Riva y Garcia Gestión SGIIC SA
![]() Riva y Garcia Gestión SGIIC SA Investment ManagersFinance Riva y Garcia Gestión SGIIC SA (Riva y Garcia) is the Barcelona-based fund management subsidiary of Riva y Garcia Proyectos, itself a subsidiary of Grupo Financiero Riva y García in Spain. Established in 1990, the firm manages funds and SICAVs for individual and institutional investors. | Direttore degli Investimenti | 01/03/2001 | - |
WeCare-U Comunicación SL
![]() WeCare-U Comunicación SL Publishing: Books/MagazinesConsumer Services WeCare-U Comunicación SL is a holding company engages in the publication and distribution of journals, periodicals, digital editions on news, and developments in the health sector. It also provides corporate communications and public relations services to clients in the healthcare industry. Its also provides services such as consulting, content design, printing, television program production, event organization, and workshop facilitation. The company was founded on September 7, 1999 and is headquartered in Madrid, Spain. | Direttore/Membro del Consiglio | - | - |
Scytl Secure Electronic Voting SA
![]() Scytl Secure Electronic Voting SA Information Technology ServicesTechnology Services Scytl Secure Electronic Voting SA provides electronic and online voting, election management and election modernization solutions. It offers election training, online voter registration, candidate management, electronic ballot delivery and results consolidation. The company was founded by Jorba Andreu Riera and Carles Rovira in 2001 and is headquartered in Barcelona, Spain. | Direttore/Membro del Consiglio | - | - |
Formazione di Albert Ferrer Olivera
Escuela Superior de Administración y Dirección de Empresas | Undergraduate Degree |
Hautes Etudes Commerciales | Graduate Degree |
Statistiche
Distribuzione geografica
Spagna | 11 |
Belgio | 2 |
Posizioni
Director/Board Member | 6 |
Private Equity Investor | 2 |
Private Equity Analyst | 1 |
Settori
Finance | 4 |
Consumer Services | 4 |
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 9 |
---|---|
Riva y García Gestión SGIIC SA /New/
![]() Riva y García Gestión SGIIC SA /New/ Investment ManagersFinance Riva y García Gestión SGIIC SA (Riva y Garcia Private Equity) is a private equity and venture capital subsidiary of Grupo Financiero Riva y García SL /New/ founded in 2000 by Borja García-Nieto Portabella. It is headquartered in Barcelona, Spain. | Finance |
Scytl Secure Electronic Voting SA
![]() Scytl Secure Electronic Voting SA Information Technology ServicesTechnology Services Scytl Secure Electronic Voting SA provides electronic and online voting, election management and election modernization solutions. It offers election training, online voter registration, candidate management, electronic ballot delivery and results consolidation. The company was founded by Jorba Andreu Riera and Carles Rovira in 2001 and is headquartered in Barcelona, Spain. | Technology Services |
WeCare-U Comunicación SL
![]() WeCare-U Comunicación SL Publishing: Books/MagazinesConsumer Services WeCare-U Comunicación SL is a holding company engages in the publication and distribution of journals, periodicals, digital editions on news, and developments in the health sector. It also provides corporate communications and public relations services to clients in the healthcare industry. Its also provides services such as consulting, content design, printing, television program production, event organization, and workshop facilitation. The company was founded on September 7, 1999 and is headquartered in Madrid, Spain. | Consumer Services |
Riva y Garcia Gestión SGIIC SA
![]() Riva y Garcia Gestión SGIIC SA Investment ManagersFinance Riva y Garcia Gestión SGIIC SA (Riva y Garcia) is the Barcelona-based fund management subsidiary of Riva y Garcia Proyectos, itself a subsidiary of Grupo Financiero Riva y García in Spain. Established in 1990, the firm manages funds and SICAVs for individual and institutional investors. | Finance |
Invivo Capital Partners SGEIC SA
![]() Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Finance |
Pulmobiotics SL
![]() Pulmobiotics SL BiotechnologyHealth Technology Pulmobiotics SL operates as a spin off company. The firm uses its technology to discover and develop novel treatments and vaccines for respiratory diseases. The company was founded by Maria Lluch and Lluis Serrano and is headquartered in Barcelona, Spain. | Health Technology |
GlyCardial Diagnostics SL
![]() GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services GlyCardial Diagnostics SL has developed a biomarker called iSCOR that can detect cardiac ischemia through a blood test. The company is based in Barcelona, Spain. Early detection of ischemia can prevent myocardial damage. The Spanish company was founded in 2017 by Rafols Judit Cubedo, Lina Badimon Maestro, Capmany Teresa Padro, and Gemma Vilahur. Rafols Judit Cubedo has been the CEO since 2017. | Commercial Services |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Commercial Services |
Gyala Therapeutics SL
![]() Gyala Therapeutics SL BiotechnologyHealth Technology Gyala Therapeutics SL develops CAR-T therapies for treating hematological malignancies. The company is based in Barcelona, Spain. Claudio Santos has been the CEO of the Spanish company since 2020. | Health Technology |